A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.
HeartPublished 1 October 1978Open access
M. F. Oliver, J. A. Heady, J Morris, Jane Cooper, H Geizerová, M Czukas
Citations1,058
SJR quartileQ1
SJR score1.78
SNIP1.47
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
Keywords
MedicineEconomics, Econometrics and FinancePharmacology, Toxicology and Pharmaceutics
Journal of the Royal Statistical Society Series B (Statistical Methodology)Regression Models and Life-Tables
39,259 Citations1972D. R. Cox
Annals of Internal MedicineCardiovascular Survey Methods.
3,072 Citations1968Geoffrey Rose, H Blackburn
New England Journal of MedicineFat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
1,923 Citations1967Donald S. Fredrickson, Robert I. Levy +1 more
BiometrikaEstimation of the probability of an event as a function of several independent variables
1,621 Citations1967Strother H. Walker, David B. Duncan
A recursive approach based on Kalman's work in linear dynamic filtering and prediction is applied, derivable also from the work of Swerling (1959), which provides an example of many other possible uses of recursive techniques in nonlinear estimation and in related areas.
CirculationThe Electrocardiogram in Population Studies
1,126 Citations1960Henry Blackburn, Ancel Keys +3 more
A classification system for the electrocardiogram in epidemiologic studies has been developed, tested, and herein presented and permits more valid comparisons of data on heart disease between populations.
The LancetISCHÆMIC HEART-DISEASE IN RELATION TO FASTING VALUES OF PLASMA TRIGLYCERIDES AND CHOLESTEROL
762 Citations1972LarsA. Carlson, L. E. Böttiger
In a nine-year follow-up of 3168 men in the Stockholm prospective study, the occurrence of new events of ischaemic heart-disease has been related to findings at the initial examination in order to identify risk factors for I.H.D.
CirculationA Controlled Clinical Trial of a Diet High in Unsaturated Fat in Preventing Complications of Atherosclerosis
599 Citations1969Seymour Dayton, Morton Lee Pearce +3 more
This report describes a clinical trial, with domiciled male veterans, designed to determine whether a diet which lowers serum cholesterol concentration can prevent overt complications of coronary heart disease and other manifestations of atherosclerosis.
International Statistical ReviewAnalysis of Survival Data under the Proportional Hazards Model
588 Citations1975N. E. Breslow
A general methodology for the statistical analysis of survival or response time data such as accrue from the long-term follow-up of patients with chronic disease is reviewed.
Annals of Internal MedicineRisk Factors in Coronary Heart Disease
539 Citations1964William B. Kannel, THOMAS R. DAWBER +3 more
Attempt will be made to assess the relative efficacy of the various lipids as predictors of coronary heart disease and to determine their independent contribution to risk of the development of the disease.
The LancetEFFECT OF CHOLESTEROL-LOWERING DIET ON MORTALITY FROM CORONARY HEART-DISEASE AND OTHER CAUSES
495 Citations1972M Miettinen, M J Karvonen +3 more
The use of the cholesterol-lowering diet was associated with considerably and significantly reduced mortality from C.H.D. and other causes and total mortality was consistently lower on this diet, although the differences were too small for statistical significance.
CirculationPrecursors of sudden coronary death. Factors related to the incidence of sudden death.
483 Citations1975William B. Kannel, Joseph T. Doyle +3 more
The inescapable conclusion is that the prevention of sudden death requires the Prevention of coronary attacks.
The LancetFÆCAL BILE-ACIDS AND CLOSTRIDIA IN PATIENTS WITH CANCER OF THE LARGE BOWEL
378 Citations1975Michael J. Hill, B. S. Drašar +5 more
New England Journal of MedicineFat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
360 Citations1967Donald S. Fredrickson, Robert I. Levy +1 more
Journal of Lipid ResearchMechanisms of action of clofibrate on cholesterol metabolism in patients with hyperlipidemia
309 Citations1972Scott M. Grundy, E. H. Ahrens +3 more
The bulk of the evidence suggests that, in all forms of hyperlipidemia except fat-induced hyperglyceridemia, the drug causes an increased output of cholesterol while simultaneously inhibiting any compensatory increase in cholesterol synthesis.
CirculationProbability of Middle-Aged Men Developing Coronary Heart Disease in Five Years
259 Citations1972Ancel Keys, Christ Aravanis +9 more
Characteristics of 11,132 men aged 40-59 years and free from coronary heart disease (CHD) at entry were related to follow-up experience, using multivariate analysis, and multiple logistic solutions usefully estimates the relative risk of CHD for individuals.
New England Journal of MedicineIncreased Prevalence of Cholelithiasis in Men Ingesting a Serum-Cholesterol-Lowering Diet
240 Citations1973Richard A.L. Sturdevant, Morton Lee Pearce +1 more
Autopsied men who ate more than 33% of the experimental meals served from entry into the trial to death were more likely to have gallstones than control subjects, and the proportion of men in the experimental diet group with gallstones at autopsy was directly correlated with number of trial meals eaten.
GastroenterologyEffects of Clofibrate and of an Estrogen-Progestin Combination on Fasting Biliary Lipids and Cholic Acid Kinetics in Man
177 Citations1974Demetrius Pertsemlidis, Dara Panveliwalla +1 more
It is suggested that increased cholesterol saturation of bile during administration of a natural estrogen with progestin to cholecystectomized patients relects an increased propensity to cholesterol formation.
New England Journal of MedicineSerum Triglycerides in Health and in Ischemic Heart Disease
168 Citations1965David F.M. Brown, Sandra H. Kinch +1 more
In this study, serum triglyceride and cholesterol levels were measured in 1851 fasting middle-aged men who remained under clinical observation for the next four years (1959–1964), and it was possible to relate lipid levels to both the incidence and the incidence of ischemic heart disease.
The LancetCANCER AMONG MEN ON CHOLESTEROL-LOWERING DIETS
140 Citations1971Fred Ederer, Paul Leren +2 more
Combined data from the five studies show that deaths from all causes were lower, though not significantly so, in the experimental groups than in the control groups, providing some reassurance that potential public-health benefits of these diets are not likely to be outweighed by any as yet unidentified hazards.
Journal of Chronic DiseasesMyocardial infarction over a five-year period—I. Prevalence, incidence and mortality experience
98 Citations1973Jack H. Medalie, Harold A. Kahn +5 more
A 5-yr follow-up of 10,059 male government and municipal employees of Israel aged 40 and over revealed a significant variation between the birth-areas in respect of age-adjusted prevalence and incidence rates of myocardial infarction as well as total mortality for all causes.
JAMAClofibrate in Coronary Heart Disease
95 Citations1972L. R. Krasno
A series of 1,001 men free of coronary heart disease and 67 with disease with an average age of 47.5 years were divided in two groups pairmatched for risk factors and one group was treated with an antilipemic agent (clofibrate) whereas the other remained untreated for 39 months.
BMJSecondary prevention trials using clofibrate: a joint commentary on the Newcastle and Scottish trials.
87 Citations1971H. A. Dewar, Michael F. Oliver
This trial was partly financed by a grant from the Scottish Home and Health Department through the Advisory Committee on Medical Research, and working protocols can be obtained on request.
Journal of the American Medical AssociationTHE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
68 Citations1912
British Journal of Pharmacology and ChemotherapySTUDIES ON THE MODE OF ACTION OF CLOFIBRATE: EFFECTS ON HORMONE‐INDUCED CHANGES IN PLASMA FREE FATTY ACIDS, CHOLESTEROL, PHOSPHOLIPIDS AND TOTAL ESTERIFIED FATTY ACIDS IN RATS AND DOGS
60 Citations1968A. M. Barrett, John M. Thorp
The present experiments were undertaken to determine whether or not clofibrate affected the level of plasma free fatty acids at rest and under conditions of stimulation and (b) experimentally induced rises in circulating cholesterol, phospholipids and total esterified fatty acids.
JAMATopics in Gastroenterology
42 Citations1977Bertram Fleshler
This volume represents a written version of the lectures given in a recent course in gastroenterology, apparently in 1976, which included discussions of computerized tomography, the H2 receptor antagonists, and the action of salicylazosulfapyridine (Azulfidine).
British Journal of Clinical PharmacologyEffect of clofibrate on glucose tolerance in maturity onset diabetes.
38 Citations1977David A. Barnett, J. F. Craig +2 more
Fourteen maturity onset diabetics showed improvement of glucose tolerance while on treatment with clofibrate, and this effect was found to be independent of concurrent treatment with oral hypoglycaemic drugs.
JAMALong-Term Treatment of Hyperlipidemic Patients With Clofibrate
34 Citations1971Donald Berkowitz
In 50 hyperlipidemic patients who responded to clofibrate during a three-month trial period, the medication was continued for six to eight years and normalization of the serum cholesterol level occurred in each patient and was maintained throughout the entire treatment period.
PubMedA cooperative trial on the primary prevention of ischaemic heart disease using clofibrate: design, methods, and progress.
34 Citations1973Heady Ja
The paper describes the design of, and the procedures used in a double blind randomized trial to determine whether the incidence of ischaemic heart disease can be lowered by the reduction of high and moderately high lipid levels in healthy men aged 30-59 years.
JAMAClofibrate in coronary heart disease. Effect on morbidity and mortality
32 Citations1972L. R. Krasno
Clinical Pharmacology & TherapeuticsXVIII. The clofibrate trials: Another dispute about contratrophic therapy
14 Citations1972Alvan R. Feinstein
In contratrophic therapy, the classical clinician and classical epidemiologist meet to engage in the new practice of prophylactic clinical medicine to prevent the development of a particular disease that has not yet occurred.
European Journal of Clinical PharmacologyEffects of clofibrate on glucose tolerance, serum insulin, serum lipoproteins and plasma fibrinogen
13 Citations1977Hans Lithell, Jonas Boberg +4 more
The results showed no effect of clofibrate treatment on glucose tolerance, as measured by an intravenous glucose tolerance test, neither in the entire group (t=0.90, 2p>0.05, n=21) nor in a subgroup (n=10) with glucose intolerance on screening, and there was, however, a significant reduction in fasting serum(S-)insulin concentration during cl ofibrate therapy.
Acta Medica ScandinavicaThe Effect of Clofibrate on Glucose Tolerance, Insulin Secretion, Triglycerides and Fibrinogen in Patients with Coronary Heart Disease
9 Citations1977Sven Chr. Enger, Villy Johnsen +2 more
The beneficial effect of clofibrate therapy on abnormal glucose tolerance observed by other workers is confirmed and it is suggested that cl ofibrate acts by reducing peripheral insulin resistance.